Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Rossari Biotech IPO.
July 1, 2024 2:30:00 PM
Biopharma deal activity plummeted down to Earth in the second quarter, with just a handful of M&A transactions and IPOs studding the mostly dark skies. | The slow quarter follows an exciting first one ...
Published by : FierceBiotechJune 28, 2024 6:32:00 PM
In all, the IPO and private placement are expected to gross $250 million, Alumis said. Alumis also granted to the IPO's underwriters a 30-day option to buy up to an additional 1,968,750 shares at the ...
Published by : The Business JournalsJune 28, 2024 8:32:00 AM
In the latest sign that biotech�s return to the public markets remains somewhat lackluster, Alumis has downsized its IPO as the company prepares to list on the Nasdaq this morning. The biotech ...
Published by : FierceBiotechJune 28, 2024 1:45:00 PM
Alumis, an immunology drug developer on the cusp of Phase 3, will go public Friday in a smaller IPO than it originally projected. The Bay Area startup sold 13.12 million shares $ALMS at $16 apiece to ...
Published by : ENDPOINTS NEWSJune 28, 2024 7:05:00 PM
Alumis is debuting in an initial public offering Friday on the Nasdaq, though the $250 million IPO is less than its initial targeted raise of $274 million just days ago.
Published by : BioSpaceOctober 12, 2023 9:50:00 PM
After a decade of significant challenges, biotech's long-term sustainability depends on making fundamental changes to its traditional business model. A commonly held perception in the biotech ...
Published by : NatureJune 24, 2024 3:47:00 PM
New York-based LB Pharmaceuticals is preparing to file for an initial public offering as investor and pharma enthusiasm grows for the neuroscience space, a source familiar with the company's plans ...
Published by : ENDPOINTS NEWSJune 15, 2024 1:06:00 AM
The firm's principals include venture capitalists, investment bankers and a former high-ranking leader at Genentech. A cadre of venture capital and investment banking veterans are supporting an ...
Published by : The Business JournalsApril 23, 2024 8:06:00 PM
Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! After a two-year dry spell, initial public offerings by biotech companies showed ...
Published by : MSNJune 28, 2024 1:44:00 PM
The offering is expected to close on 1 July. Earlier this month, the US-based biotech said that it planned to use part of the IPO proceeds to advance its lead asset ESK-001 into multiple Phase III ...
Published by : Yahoo FinanceDecember 3, 2023 8:28:00 AM
In recent years, the Indian equity market has witnessed an astounding surge in IPO activity, defying global economic uncertainties and underscoring the resilience of the Indian economy. Post the ...
Published by : MSNMay 5, 2023 3:30:00 AM
The company raised $540 million from the sale of 30 million shares at $18 apiece, in the largest biotech IPO in the US since Sana Biotech went public in early 2021 with a $588 million raise that ...
Published by : pharmaphorumThe IPO Shares of Rossari Biotech Ltd IPO are proposed to list on Tuesday, July 21, 2020 at BSE, NSE. The public issue of Rossari Biotech IPO was opened on Jul 13, 2020 and closed for subscription on Jul 15, 2020. Rossari Biotech IPO Listing Date and Information:
| Listing Date | Tuesday, July 21, 2020 |
| BSE Script Code | 543213 |
| NSE Symbol | ROSSARI |
| Listing In | B Group of Securities |
| ISIN | INE02A801020 |
| Issue Price | Rs 425 Per Equity Share |
| Face Value | Rs 2 Per Equity Share |
The allotment status of Rossari Biotech Ltd IPO is now available online. The public issue of Rossari Biotech IPO was open on Jul 13, 2020 and closed for subscription on Jul 15, 2020. The equity shares of the company to be list at BSE, NSE.
Rossari Biotech Ltd is entering in the capital market with an IPO of [.] Equity Shares of Rs [.] aggregating up to Rs [.] Crore. The price for the issue has been set at Rs - Rs Per Equity Share.
Incorporated in 2009, Rossari Biotech Ltd is a manufacturer of textiles specialty chemicals. It provides customized solutions to the apparel, animal & poultry feed, and FMCG industries by offering a diversified product portfolio. Rossari Biotech operates in 18 countries including India, Bangladesh, Vietnam, and Mauritius.
The issue opens on Jul 13, 2020 and closes for subscription on Jul 15, 2020. The equity shares of the company to be list at BSE, NSE.
The issue of Rossari Biotech Ltd opens on Jul 13, 2020 and closes for subscription on Jul 15, 2020. The equity shares of the company to be list at BSE, NSE. The price for the issue has been set at Rs - Rs Per Equity Share.
The Rossari Biotech IPO is proposed to open on July 13, 2020. The IPO application ends on July 15, 2020.
Retail investors can apply in the retail or non-institutional investor category from July 13, 2020 to July 15, 2020. The Rossari Biotech IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Rossari Biotech IPO will open for subscription on July 13, 2020. The public issue will close on July 15, 2020.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
